Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Progenics Pharmaceuticals, Inc. News

Lantheus Acquires Progenics in All-Stock Deal, Both Companies Drop in Trading

Lantheus will acquire oncology medicine developer Progenics Pharmaceuticals in an all-stock deal.

Biotech premarket movers: Progenics, Alexion, BioCryst

Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.

4 biotech stock charts you must see

Biotech stocks dominate our list of top charts today. Here are four to watch.

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.

Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a "perilous reversal" (up big yesterday but down big today) candidate

Breaking News

Costco May Have a Huge Workers Problem

Workers demand for their needs to be met.

Real Estate Titan Zillow Sees Tough Times Ahead in Housing

The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.

Meta (Facebook) Looks to Take on TikTok Next

Facebook and Instagram's parent company has a plan to take over a new segment.